Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Stoke Therapeutics (STOK) Non Operating Income: 2022-2024

Historic Non Operating Income for Stoke Therapeutics (STOK) over the last 3 years, with Dec 2024 value amounting to $12.4 million.

  • Stoke Therapeutics' Non Operating Income fell 2.99% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.4 million, marking a year-over-year increase of 12.87%. This contributed to the annual value of $12.4 million for FY2024, which is 23.00% up from last year.
  • Per Stoke Therapeutics' latest filing, its Non Operating Income stood at $12.4 million for FY2024, which was up 23.00% from $10.1 million recorded in FY2023.
  • Stoke Therapeutics' Non Operating Income's 5-year high stood at $12.4 million during FY2024, with a 5-year trough of $3.3 million in FY2022.
  • Over the past 3 years, Stoke Therapeutics' median Non Operating Income value was $10.1 million (recorded in 2023), while the average stood at $8.6 million.
  • Data for Stoke Therapeutics' Non Operating Income shows a peak YoY surged of 206.29% (in 2023) over the last 5 years.
  • Stoke Therapeutics' Non Operating Income (Yearly) stood at $3.3 million in 2022, then soared by 206.29% to $10.1 million in 2023, then climbed by 23.00% to $12.4 million in 2024.